Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

CUSIP: 761330109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
104,661,494
Total 13F shares
43,555,026
Share change
+2,082,014
Total reported value
$564,029,588
Put/Call ratio
187%
Price per share
$12.97
Number of holders
110
Value change
+$26,762,019
Number of buys
62
Number of sells
40

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
5.5%
5,744,134
$90,528,000 31 Mar 2019
13F
JPMORGAN CHASE & CO
13F
Company
3.7%
3,897,850
$61,431,000 31 Mar 2019
13F
BlackRock Finance, Inc.
13F
Company
3.4%
3,550,138
$55,951,000 31 Mar 2019
13F
FRANKLIN RESOURCES INC
13F
Company
3.3%
3,429,256
$54,045,000 31 Mar 2019
13F
ArrowMark Colorado Holdings LLC
13F
Company
3.3%
3,409,217
$53,729,000 31 Mar 2019
13F
Essex Woodlands Management, Inc.
13F
Company
3.2%
3,342,047
$52,671,000 31 Mar 2019
13F
Bank of New York Mellon Corp
13F
Company
2.2%
2,292,785
$36,135,000 31 Mar 2019
13F
VANGUARD GROUP INC
13F
Company
2%
2,102,700
$33,138,000 31 Mar 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
2%
2,041,129
$32,168,000 31 Mar 2019
13F
Capital World Investors
13F
Company
1.6%
1,685,000
$26,556,000 31 Mar 2019
13F
NovaQuest Capital Management, L.L.C.
13F
Company
1.5%
1,558,426
$24,561,000 31 Mar 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.86%
902,073
$14,217,000 31 Mar 2019
13F
STATE STREET CORP
13F
Company
0.78%
813,443
$12,820,000 31 Mar 2019
13F
BAMCO INC /NY/
13F
Company
0.49%
509,200
$8,025,000 31 Mar 2019
13F
NORTHERN TRUST CORP
13F
Company
0.48%
498,934
$7,864,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.47%
488,347
$7,696,000 31 Mar 2019
13F
Fosun International Ltd
13F
Company
0.45%
472,532
$7,447,000 31 Mar 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.45%
470,747
$7,417,000 31 Mar 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.36%
373,904
$5,893,000 31 Mar 2019
13F
Capital International Investors
13F
Company
0.31%
325,000
$5,122,000 31 Mar 2019
13F
Sio Capital Management, LLC
13F
Company
0.24%
254,581
$4,012,000 31 Mar 2019
13F
S.c.a. Candriam
13F
Individual
0.23%
237,000
$3,735,000 31 Mar 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.22%
225,381
$3,553,000 31 Mar 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.2%
206,451
$3,253,000 31 Mar 2019
13F
Rhenman & Partners Asset Management AB
13F
Company
0.18%
193,181
$3,045,000 31 Mar 2019
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.13%
135,902
$2,141,000 31 Mar 2019
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.11%
117,068
$1,845,000 31 Mar 2019
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.11%
117,012
$1,844,000 31 Mar 2019
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.11%
114,268
$1,801,000 31 Mar 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
112,458
$1,772,000 31 Mar 2019
13F
MORGAN STANLEY
13F
Company
0.1%
108,216
$1,706,000 31 Mar 2019
13F
TEACHERS ADVISORS, LLC
13F
Company
0.1%
107,067
$1,687,000 31 Mar 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.08%
82,323
$1,297,000 31 Mar 2019
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.08%
82,137
$1,294,000 31 Mar 2019
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.07%
71,300
$1,124,000 31 Mar 2019
13F
Swiss National Bank
13F
Company
0.07%
69,450
$1,095,000 31 Mar 2019
13F
FMR LLC
13F
Company
0.06%
64,300
$1,013,000 31 Mar 2019
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.06%
64,068
$1,010,000 31 Mar 2019
13F
QS Investors, LLC
13F
Company
0.06%
63,161
$996,000 31 Mar 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.06%
59,257
$934,000 31 Mar 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.05%
57,405
$905,000 31 Mar 2019
13F
Quinn Opportunity Partners LLC
13F
Company
0.05%
56,672
$893,000 31 Mar 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.05%
51,755
$816,000 31 Mar 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
49,124
$774,000 31 Mar 2019
13F
MFN Partners Management, LP
13F
Company
0.04%
46,000
$725,000 31 Mar 2019
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.03%
36,200
$571,000 31 Mar 2019
13F
Cubist Systematic Strategies, LLC
13F
Company
0.03%
35,511
$560,000 31 Mar 2019
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.03%
35,199
$555,000 31 Mar 2019
13F
BARCLAYS PLC
13F
Company
0.03%
33,477
$529,000 31 Mar 2019
13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
13F
Company
0.03%
33,131
$522,000 31 Mar 2019
13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2019

As of 30 Jun 2019, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,555,026 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ArrowMark Colorado Holdings LLC, BlackRock Inc., FRANKLIN RESOURCES INC, Essex Woodlands Management, Inc., JPMORGAN CHASE & CO, Bank of New York Mellon Corp, VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., and Capital World Investors. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
108
Q2 2019 holders
110
Holder diff
2
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.